Baseline Characteristics Associated with PSA Progression-Free Survival in Patients (pts) with High-Risk Biochemically Relapsed Prostate Cancer: Results from the Phase 3 PRESTO study (AFT-19)
- Citation:
- J Clin Oncol vol 41 (6) 208
- Meeting Instance:
- ASCO GU 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Funding:
- AFT
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 4065
- Pharmas:
- Janssen
- Grants:
- Corr. Author:
- Authors:
- Rahul Aggarwal Glenn Heller David Hillman Han Xiao Joel Picus Mary-Ellen Taplin Tanya Dorff Leonard Appleman Douglas Weckstein Akash Patnaik Alan Bryce Daniel Shevrin James Mohler Daniel Anderson Arpit Rao Scott Tagawa Alan Tan Scott E. Eggener Charles J. Ryan Michael J. Morris
- Networks:
- CA043, CA136, IL018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY016, LAPS-NY158, LAPS-PA015, METROMIN, MN022, NH038, NY018, TX041
- Study
- AFT-19
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: